U.S. Stock News

Why ServiceTitan is on investors’ radar ServiceTitan (TTAN) has come into focus after a sharp share price pullback, with the stock showing a 32% decline over the past month and a 30% decline over the past 3 months. For investors watching software names tied to real world trade services, this recent performance is prompting closer attention to how the company’s growth profile lines up with its current valuation and business scale. See our latest analysis for ServiceTitan. At the current share...

Addus HomeCare Corporation has reported its fourth-quarter and full-year 2025 results, with full-year net income rising to US$95.91 million and diluted earnings per share from continuing operations reaching US$5.22. The company’s quarter featured higher-than-expected adjusted earnings of US$1.77 per share and improved operating margins, pointing to increased efficiency in its home-care operations. We’ll now examine how this margin expansion and earnings outperformance might influence Addus...

Earnings and guidance put Sabra Health Care REIT in focus Sabra Health Care REIT (SBRA) moved into the spotlight after reporting its fourth quarter and full year 2025 results, alongside issuing 2026 earnings guidance that outlines expected net income per diluted share. See our latest analysis for Sabra Health Care REIT. At a share price of $20.43, Sabra’s recent 1 month share price return of 8.55% and 1 year total shareholder return of 37.23% indicate that momentum has been building around...

CareTrust REIT (CTRE) has drawn fresh attention after filing a US$1b at-the-market follow-on equity offering and a broad shelf registration, closely following its latest earnings and updated 2026 profit guidance. See our latest analysis for CareTrust REIT. The at the market offering comes after a strong run, with a 30 day share price return of 9.9% and a year to date share price gain of 11.54%. The 1 year total shareholder return of 68.61% and 3 year total shareholder return of 134.68%...

If you have been watching lululemon athletica and wondering whether the current share price offers good value, this breakdown will help you frame the numbers in a clear way. The stock last closed at US$178.11, with returns of 1.0% over 7 days, a 6.8% decline over 30 days, a 15.5% decline year to date, and a 51.6% decline over 1 year. The 3 year and 5 year returns sit at 42.6% and 43.4% declines respectively. Recent coverage around lululemon athletica has focused on how the brand is...

If you are wondering whether Kraft Heinz is a bargain or a value trap at around US$24.54, this article walks through what the numbers are actually saying about the stock. The share price has been mixed recently, with a 1% decline over the last 7 days, a 5.8% gain over 30 days, and returns of 0.6% year to date, but 17.1% and 28.1% declines over the past 1 and 3 years, and a 16.5% decline over 5 years. These moves sit against a backdrop where Kraft Heinz continues to operate in the packaged...

Clean Harbors (CLH) is back in focus after reporting fourth quarter and full year 2025 results that topped revenue and adjusted EBITDA expectations, along with 2026 guidance and a larger share repurchase authorization. See our latest analysis for Clean Harbors. That backdrop of strong Q4 results, higher 2026 guidance, an expanded buyback authorization and the planned Depot Connect acquisition has coincided with a 25.44% 3 month share price return and a 32.68% 1 year total shareholder return...

If you are wondering whether F&G Annuities & Life is quietly turning into a value opportunity or just looks cheap on the surface, it helps to step back from the headlines and focus on what the numbers actually say. The share price closed at US$23.32, with returns of an 18% decline over 7 days, a 16.4% decline over 30 days, a 22.4% decline year to date and a 41.5% decline over the past year, while the 3 year return sits at 20.4%. Recent news coverage has largely centered on the company as an...

If you are wondering whether Charter Communications' current share price reflects its true worth, you are not alone. This article focuses squarely on what the recent numbers might be telling you about value. The stock last closed at US$227.52, with a 30 day return of 18.7% and a 7 day return of 4.8% decline, set against a 1 year return of 37.8% decline, a 3 year return of 39.3% decline and a 5 year return of 63.3% decline. Recent price moves come against a backdrop of ongoing attention on...

If you are wondering whether RLI is attractively priced or looking stretched, this article will walk you through what the current numbers say about its valuation. RLI shares last closed at US$60.03. The stock has returned 5.4% over 30 days, declined 2.6% over 7 days, declined 3.9% year to date, declined 16.5% over 1 year and gained 35.9% over 5 years. These moves may have shifted how some investors view its risk and return profile. Recent coverage around RLI has focused on its position in...

In February 2026, Target announced a major leadership reshuffle under new CEO Michael Fiddelke, confirmed its 2025 earnings guidance, and began cutting around 500 corporate, regional and supply-chain roles to redirect investment toward better-staffed stores and an improved in-person shopping experience. At the same time, brand partner Edna’s Non-Alcoholic Cocktail Co. expanded its presence to 1,000 Target locations with premium endcap placement, highlighting how curated assortments and...

In February 2026, La-Z-Boy reported third-quarter and nine‑month results showing modest year‑over‑year sales growth to US$541.59 million and US$1.56 billion respectively, but lower net income and earnings per share, while also declaring a US$0.242 quarterly dividend and issuing fourth‑quarter sales guidance of US$560 million to US$580 million. These updates, released just as a new 15% global tariff reignited trade uncertainty, highlight how La-Z-Boy’s vertically integrated model and ongoing...

In recent days, a US federal appeals court reversed an earlier ruling that had favored Sarepta Therapeutics in its patent dispute with Regenxbio over AAV gene delivery technology used in Duchenne muscular dystrophy treatment Elevidys, sending the case back for further proceedings. This legal shift raises fresh questions around Sarepta’s access to critical gene therapy technology, adding another layer of uncertainty to its rare disease portfolio. Next, we’ll examine how this setback in...

Without a clear single headline event, Global Ship Lease (GSL) is drawing attention as investors look at its container ship chartering business, its recent share performance, and how its fundamentals line up with current market expectations. See our latest analysis for Global Ship Lease. At a share price of US$39.48, Global Ship Lease has had a firm run, with a 30 day share price return of 9.39% and a 1 year total shareholder return of 90.80%. This points to strong recent momentum and a...

Q4 earnings, 2026 guidance and higher dividend put InvenTrust in focus InvenTrust Properties (IVT) has come into focus after releasing fourth quarter and full year 2025 results, issuing 2026 net income guidance, and approving a 5% increase to its annual dividend. See our latest analysis for InvenTrust Properties. The recent earnings release, new 2026 net income guidance and 5% dividend increase appear to have supported momentum, with a 30 day share price return of 6.7% and a 5 year total...

Liquid Networx has become North America’s first Fortinet Engage Preferred Services Partner. The partnership expansion focuses on delivering dedicated, certified Fortinet engineers to enterprise customers. Clients gain support for Fortinet’s SASE, Zero Trust, and Security Fabric solutions through the new services model. For investors watching Fortinet, NasdaqGS:FTNT, this partnership adds another data point to the company’s channel driven approach. The stock closed at $75.6, with a 3 year...

If you are wondering whether American Eagle Outfitters at around US$23.65 is still good value after a strong run, this article will walk through what the numbers are really saying about the stock today. The share price is down 7.2% over the past week and 2.0% over the past month, yet it still shows a 10.3% decline year to date against a 76.6% return over the last year and 77.2% over three years. This can leave investors questioning whether recent weakness changes the longer term...

Centrus Energy is expanding its Ohio enrichment plant to help fill a domestic enriched uranium supply gap created by a U.S. ban on Russian imports. The move highlights the company’s role as a licensed U.S. uranium enricher serving current and next generation nuclear reactors. The development comes as Centrus Energy reports a substantial sales backlog tied to long term nuclear fuel contracts. Centrus Energy (NYSE:LEU), trading at $200.99, is positioned at the center of a key shift in U.S...

Why Equitable Holdings Stock Is On Investors’ Radar Equitable Holdings (EQH) is drawing attention after a stretch of weaker share performance, including a 9% move lower over the past week and a 12% decline over the past month. Those moves sit alongside a mixed picture, with a 37% total return over the past 3 months and 50% over 5 years, and recent annual figures showing revenue of US$11.7b and a net loss of US$1.4b. See our latest analysis for Equitable Holdings. With the share price at...

Chemours (NYSE:CC) has expanded its semiconductor engagement with the appointment of Gerardo Familiar to the SEMI North America Advisory Board. The company is selling its Kuan Yin site, with proceeds intended to reduce debt and simplify its portfolio. Chemours reports record adoption of its Opteon refrigerants, even as it faces operational disruptions and weaker performance in Advanced Performance Materials. Chemours, a chemistry focused company, is working to tighten its link to the...

AI driven pathology rollout puts Labcorp Holdings (LH) in focus Labcorp Holdings (LH) is back on investors’ radar after expanding its collaboration with PathAI. The companies plan to roll out the FDA cleared AISight Dx digital pathology platform across Labcorp’s national anatomic pathology network. See our latest analysis for Labcorp Holdings. Labcorp’s 1 month share price return of 6.99% and year to date share price return of 13.37% suggest momentum has been building, while the 5 year total...

If you are wondering whether Li Auto's current share price really reflects its potential, you are not alone. This article walks through what the numbers actually say about value. After recent volatility, Li Auto now trades at US$18.43, with returns of 10.3% over 30 days, 6.8% year to date, a 0.2% decline over 7 days and a 30.1% decline over 1 year. These moves can change how investors think about both opportunity and risk. Recent news around Li Auto has largely centered on its position in...

If you are wondering whether Appian is starting to look interesting at its current share price, this breakdown will help you judge what you are really paying for. The stock closed at US$24.25, with a 6.0% gain over the last 7 days, but a 18.4% decline over 30 days and a 28.8% decline year to date, alongside a 27.0% decline over 1 year, 42.0% over 3 years and 87.0% over 5 years. These moves sit against a backdrop where Appian has continued to attract attention as a low code software platform,...

Why Everus Construction Group Stock Is Back in Focus Everus Construction Group (ECG) is drawing fresh investor attention after its shares touched an all time high of $108.96 and the company dismissed Deloitte & Touche LLP as its auditing firm. See our latest analysis for Everus Construction Group. The latest pullback, with a 1 day share price return of 1.92% to $106.08, comes after a strong recent run that includes a 16.29% 30 day share price return and a 174.68% 1 year total shareholder...